APA (7th ed.) Citation

Pfeifer, H., Wassmann, B., Bethge, W., Dengler, J., Bornhäuser, M., Stadler, M., . . . Brück, P. (2013). Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia. Leukemia (08876924), 27(6), 1254. https://doi.org/10.1038/leu.2012.352

Chicago Style (17th ed.) Citation

Pfeifer, H., et al. "Randomized Comparison of Prophylactic and Minimal Residual Disease-triggered Imatinib After Allogeneic Stem Cell Transplantation for BCR-ABL1-positive Acute Lymphoblastic Leukemia." Leukemia (08876924) 27, no. 6 (2013): 1254. https://doi.org/10.1038/leu.2012.352.

MLA (9th ed.) Citation

Pfeifer, H., et al. "Randomized Comparison of Prophylactic and Minimal Residual Disease-triggered Imatinib After Allogeneic Stem Cell Transplantation for BCR-ABL1-positive Acute Lymphoblastic Leukemia." Leukemia (08876924), vol. 27, no. 6, 2013, p. 1254, https://doi.org/10.1038/leu.2012.352.